Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO‐3 randomized trial.

Published in:

Catheterization & Cardiovascular Interventions, 2020, v. 96, n. 3, p. E377, doi. 10.1002/ccd.28642

By:

• Zilberszac, Robert;
• Chandiramani, Rishi;
• Hengstenberg, Christian;
• Sartori, Samantha;
• Cao, Davide;
• Chandrasekhar, Jaya;
• Schafer, Ulrich;
• Tchetche, Didier;
• Violini, Roberto;
• Jeger, Raban;
• Van Belle, Eric;
• Boekstegers, Peter;
• Hambrecht, Rainer;
• Tron, Christophe;
• Dumenteil, Nicolas;
• Linke, Axel;
• ten Berg, Jurriën M.;
• Deliargyris, Efthymios N.;
• Anthopoulos, Prodromos;
• Mehran, Roxana

Publication type:

Article